- Home
- ATR vs PEN Comparison
ATR vs PEN Comparison
Compare ATR & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATR
- PEN
- Stock Information
- Founded
- ATR 1992
- PEN 2004
- Country
- ATR United States
- PEN United States
- Employees
- ATR N/A
- PEN N/A
- Industry
- ATR Plastic Products
- PEN Medical/Dental Instruments
- Sector
- ATR Industrials
- PEN Health Care
- Exchange
- ATR Nasdaq
- PEN Nasdaq
- Market Cap
- ATR 9.3B
- PEN 9.7B
- IPO Year
- ATR 1993
- PEN 2015
- Fundamental
- Price
- ATR $128.73
- PEN $253.70
- Analyst Decision
- ATR Buy
- PEN Strong Buy
- Analyst Count
- ATR 4
- PEN 16
- Target Price
- ATR $176.00
- PEN $304.38
- AVG Volume (30 Days)
- ATR 387.3K
- PEN 319.8K
- Earning Date
- ATR 10-30-2025
- PEN 11-05-2025
- Dividend Yield
- ATR 1.49%
- PEN N/A
- EPS Growth
- ATR 21.86
- PEN 916.05
- EPS
- ATR 5.79
- PEN 3.74
- Revenue
- ATR $3,610,693,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- ATR $4.27
- PEN $15.52
- Revenue Next Year
- ATR $4.84
- PEN $14.20
- P/E Ratio
- ATR $22.26
- PEN $67.67
- Revenue Growth
- ATR 1.51
- PEN 12.92
- 52 Week Low
- ATR $127.85
- PEN $203.72
- 52 Week High
- ATR $178.03
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- ATR 37.34
- PEN 49.54
- Support Level
- ATR $128.02
- PEN $248.22
- Resistance Level
- ATR $132.11
- PEN $255.45
- Average True Range (ATR)
- ATR 2.12
- PEN 7.26
- MACD
- ATR 0.25
- PEN -0.02
- Stochastic Oscillator
- ATR 17.64
- PEN 47.97
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.